{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T12:44:21Z","timestamp":1747226661678,"version":"3.40.5"},"reference-count":14,"publisher":"Weston Medical Publishing","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Opioid Management"],"abstract":"<jats:p>Objective: To examine analgesic methadone prescriptions among community health center (CHC) patients with chronic pain.\r\nDesign: Observational; two cross-sectional periods.\r\nSetting: Oregon and California CHCs.\r\nPatients: Chronic pain patients with \u22651 visit in 2012-2013 or 2017-2018 (N = 158,239).\r\nOutcomes: Changes in adjusted relative rates (aRRs) of receiving no opioids, short-acting only, long-acting only other than methadone, and methadone; characteristics associated with \u22651 methadone prescription.\r\nResults: Opioid prescribing declined over time, with the largest decrease in methadone (aRR = 0.19, 95 percent confidence interval: 0.14-0.27). Among patients receiving \u22651 long-acting opioid, variables associated with methadone prescribing included being aged &lt;65 years, having nonprivate insurance, and an opioid use disorder (OUD) diagnosis. From 2012-2013 to 2017-2018, aRR increased among patients with OUD and decreased for those aged 18-30 (vs \u226565), uninsured and Medicaid-insured (vs private), and race\/ethnicity other than non-Hispanic Black (vs non-Hispanic White).\r\nConclusions: Methadone prescribing decreased in CHCs but remained elevated for several high-risk demographic groups.<\/jats:p>","DOI":"10.5055\/jom.0811","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T21:43:49Z","timestamp":1700516629000},"page":"369-375","source":"Crossref","is-referenced-by-count":1,"title":["Analgesic methadone prescribing in community health centers among patients with chronic pain"],"prefix":"10.5055","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4482-8083","authenticated-orcid":false,"given":"Steffani R.","family":"Bailey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean P.","family":"O\u2019Malley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel M.","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Marino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Muench","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3008","published-online":{"date-parts":[[2023,11,20]]},"reference":[{"key":"87227","doi-asserted-by":"crossref","unstructured":"Rajan J, Scott-Warren J: The clinical use of methadone in cancer and chronic pain medicine. BJA Educ. 2016; 16(3): 102-106. DOI: 10.1093\/bjaceaccp\/mkv023.","DOI":"10.1093\/bjaceaccp\/mkv023"},{"key":"87228","doi-asserted-by":"crossref","unstructured":"Faul M, Bohm M, Alexander C: Methadone prescribing and overdose and the association with Medicaid preferred drug list policies\u2014United States, 2007-2014. MMWR Morb Mortal Wkly Rep. 2017; 66(12): 320-323. DOI: 10.15585\/mmwr.mm6612a2.","DOI":"10.15585\/mmwr.mm6612a2"},{"key":"87229","unstructured":"Centers for Disease Control and Prevention (CDC): Vital signs: Risk for overdose from methadone used for pain relief\u2014United States, 1999-2010. MMWR Morb Mortal Wkly Rep. 2012; 61(26): 493-497."},{"key":"87230","doi-asserted-by":"crossref","unstructured":"Dowell D, Haegerich TM, Chou R: CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016. MMWR Recomm Rep. 2016; 65(1): 1-49. DOI: 10.15585\/mmwr.rr6501e1.","DOI":"10.15585\/mmwr.rr6501e1"},{"key":"87231","unstructured":"The Pew Charitable Trusts: The use of methadone for pain by Medicaid patients: An examination of prescribing patterns and drug use. 2018. Available at https:\/\/www.pewtrusts.org\/~\/media\/assets\/2018\/03\/use_of_methadone_report_v1.pdf. Accessed September 12, 2022."},{"key":"87232","doi-asserted-by":"crossref","unstructured":"Devoe JE, Sears A: The OCHIN community information network: Bringing together community health centers, information technology, and data to support a patient-centered medical village. J Am Board Fam Med. 2013; 26(3): 271-278. DOI: 10.3122\/jabfm.2013.03.120234.","DOI":"10.3122\/jabfm.2013.03.120234"},{"key":"87233","unstructured":"US Department of Agriculture ERS: Rural\u2013urban commuting area codes. Available at https:\/\/www.ers.usda.gov\/dataproducts\/rural-urban-commuting-area-codes.aspx. Accessed November 17, 2022."},{"key":"87234","doi-asserted-by":"crossref","unstructured":"Webster L, Gudin J, Raffa RB, et al.: Understanding buprenorphine for use in chronic pain: Expert opinion. Pain Med. 2020; 21(4): 714-723. DOI: 10.1093\/pm\/pnz356.","DOI":"10.1093\/pm\/pnz356"},{"key":"87235","unstructured":"SAS User Guide: The genmod procedure. Available at http:\/\/documentation.sas.com\/doc\/en\/pgmsascdc\/9.4_3.4\/statug\/statug_genmod_details29.htm. Accessed June 12, 2023."},{"key":"87236","doi-asserted-by":"crossref","unstructured":"Muench J, Fankhauser K, Voss RW, et al.: Assessment of opioid prescribing patterns in a large network of US community health centers, 2009 to 2018. JAMA Netw Open. 2020; 3(9): e2013431. DOI: 10.1001\/jamanetworkopen.2020.13431.","DOI":"10.1001\/jamanetworkopen.2020.13431"},{"key":"87237","doi-asserted-by":"crossref","unstructured":"Guy GP Jr, Zhang K, Bohm MK, et al.: Vital signs: Changes in opioid prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017; 66(26): 697-704. DOI: 10.15585\/mmwr.mm6626a4.","DOI":"10.15585\/mmwr.mm6626a4"},{"key":"87238","doi-asserted-by":"crossref","unstructured":"Jones CM, Baldwin GT, Manocchio T, et al.: Trends in methadone distribution for pain treatment, methadone diversion, and overdose deaths\u2014United States, 2002-2014. MMWR Morb Mortal Wkly Rep. 2016; 65(26): 667-671. DOI: 10.15585\/mmwr.mm6526a2.","DOI":"10.15585\/mmwr.mm6526a2"},{"key":"87239","doi-asserted-by":"crossref","unstructured":"Adalbert JR, Varshney K, Hom J, et al.: Methadone prescribing for pain management in Pennsylvania per the prescription drug monitoring program, 2016\u20132020. Cureus. 2022; 14(8): e28583.","DOI":"10.7759\/cureus.28583"},{"key":"87240","doi-asserted-by":"crossref","unstructured":"Hoopsick RA, Homish GG, Leonard KE: Differences in opioid overdose mortality rates among middle-aged adults by race\/ethnicity and sex, 1999-2018. Public Health Rep. 2021; 136(2): 192-200. DOI: 10.1177\/0033354920968806.","DOI":"10.1177\/0033354920968806"}],"container-title":["Journal of Opioid Management"],"original-title":[],"link":[{"URL":"https:\/\/wmpllc.org\/ojs\/index.php\/jom\/article\/download\/3532\/3823","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/wmpllc.org\/ojs\/index.php\/jom\/article\/download\/3532\/3823","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T21:45:16Z","timestamp":1700516716000},"score":1,"resource":{"primary":{"URL":"https:\/\/wmpllc.org\/ojs\/index.php\/jom\/article\/view\/3532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,20]]},"references-count":14,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,11,20]]}},"URL":"https:\/\/doi.org\/10.5055\/jom.0811","relation":{},"ISSN":["1551-7489","1551-7489"],"issn-type":[{"type":"electronic","value":"1551-7489"},{"type":"print","value":"1551-7489"}],"subject":[],"published":{"date-parts":[[2023,11,20]]}}}